Published: 2019-09-03

Behçet’s disease in the United States: A single center descriptive and comparative study

Nathan C. Kilian, Amr H. Sawalha

(239-244)

DOI: https://doi.org/10.5152/eurjrheum.2017.17112

Low frequency of HLA-B27 in ankylosing spondylitis and its relationship with clinical findings in patients from Turkey

Sevde Nur Fırat, Ayten Yazıcı, Barış Yılmazer, Fulya Coşan, Hakan Savlı, Ayşe Cefle

(268-271)

DOI: https://doi.org/10.5152/eurjrheum.2017.17015

Case series: Monoarticular rheumatoid arthritis

Jeffrey Sarazin, Elena Schiopu, Rajaie Namas

(264-267)

DOI: https://doi.org/10.5152/eurjrheum.2017.17011

Ultrasonographic clues for acuity/chronicity of rotator cuff tear

Suheil Artul, George Habib

(260-263)

DOI: https://doi.org/10.5152/eurjrheum.2017.17047

The real-world use of different anti-tumor necrosis factor agents in a Northern European population of patients with Behçet’s disease

Fahd Adeeb, Wan Lin Ng, Maria Usman Khan, Joseph Devlin, Austin G. Stack, Alexander Duncan Fraser

(254-259)

DOI: https://doi.org/10.5152/eurjrheum.2017.17046

ABO blood groups and rheumatic diseases

Songül Çildağ, Yasemin Kara, Taşkın Şentürk

(250-253)

DOI: https://doi.org/10.5152/eurjrheum.2017.17044

Fibromyalgia has a high prevalence and impact in cardiac failure patients

Anthea C. Gist, Emma K. Guymer, Andrew E. Ajani, Geoffrey O. Littlejohn

(245-249)

DOI: https://doi.org/10.5152/eurjrheum.2017.17026

Erratum

Aves Editorial Aves Editorial

(307-307)

DOI: https://doi.org/10.5152/eurjrheum.2017.17004

An unusual flare of anti-synthetase syndrome during concurrent trastuzumab therapy given for recurrent breast cancer

Timothy D. Reynolds, Vivek Mohan, Matthew Roy, Nathan Manghat, Huzaifa Adamali, Harsha Gunawardena

(278-280)

DOI: https://doi.org/10.5152/eurjrheum.2017.17036

Microscopic polyangiitis with dermatomyositis

Erin M. Bauer, Ernest Brahn

(291-293)

DOI: https://doi.org/10.5152/eurjrheum.2017.17008

Rapid loss of efficacy of biosimilar infliximab in three patients with Behçet’s disease after switching from infliximab originator

Fabrizio Cantini, Laura Niccoli, Carlotta Nannini, Emanuele Cassarà, Olga Kaloudi

(288-290)

DOI: https://doi.org/10.5152/eurjrheum.2017.16112

Familial sarcoidosis: Report of a mother and her son

Ekin Akyıldız, Şenol Kobak

(284-287)

DOI: https://doi.org/10.5152/eurjrheum.2017.17029

Catastrophic antiphospholipid syndrome: A case with unusual findings revealed in autopsy and a brief literature update

Flavio Signorelli, Gustavo Guimarães Moreira Balbi, Roger A. Levy

(281-283)

DOI: https://doi.org/10.5152/eurjrheum.2017.17023

Top 100 cited articles in the field of rheumatology

Yu Heng Kwan, Chi Jun Chua, Jing Xun Lester Kian, Warren Fong

(294-304)

DOI: https://doi.org/10.5152/eurjrheum.2017.17027

Targeting IL-17 in psoriatic arthritis

Elizabeth A. Wang, Erika Suzuki, Emanual Maverakis, Iannis E. Adamopoulos

(272-277)

DOI: https://doi.org/10.5152/eurjrheum.2017.17037

Cutaneous calcinosis in a patient with limited scleroderma: CREST Syndrome

Nurşen Düzgün

(305-306)

DOI: https://doi.org/10.5152/eurjrheum.2017.17034

REVIEWER LIST

Aves Editorial Aves Editorial

(308-308)